Zymeworks, Inc. (ZYME)
27.78
+0.58
(+2.13%)
USD |
NASDAQ |
Apr 17, 12:00
Zymeworks Free Cash Flow : -35.43M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Royalty Pharma Plc | 897.24M |
| Krystal Biotech, Inc. | 188.91M |
| Scholar Rock Holding Corp. | -300.64M |
| Xeris Biopharma Holdings, Inc. | 27.93M |
| Stoke Therapeutics, Inc. | 44.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.979M |
| Cash from Investing (Quarterly) | 5.097M |
| Cash from Financing (Quarterly) | -18.78M |
| Free Cash Flow Per Share (Quarterly) | -0.1417 |
| Free Cash Flow to Equity (Quarterly) | -10.04M |
| Free Cash Flow to Firm (Quarterly) | -10.68M |
| Free Cash Flow Yield | -1.68% |